References
- Bass P, Wiley JN. Endorphins; new gut peptides with a familiar face. Gastroenterology 1965; 208: 908
- Bueno L, Fioramonti J. A possible central serotonergic mechanism involved in the effects of morphine on colonic motility in the dog. Eur J Pharmacol 1982; 82: 147
- Burks TF, Hirning LD, Galligan JJ, Davis TP. Motility effects of opioid peptides in dog intestine. Life Sci 1982; 31: 2237
- Vaught Jl, Cowan A, Jacoby HI. ü.and dˆ, but not, opioid agonists induce contractions of the canine small intestine in vivo. Eur J Pharmacol 1985; 109: 43–8
- Hirning LD, Porreca F, Burks TF. ü. but not, opioid agonists induce contractions of the canine small intestine ex vivo. Eur J Pharmacol 1985; 109: 49–54
- Kamikawa Y, Shimo Y. Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus. Br J Pharmacol 1983; 78: 693–9
- Traynor JR, Corbett AD, Kosterlitz HW. Diprenorphine has agonist activity at opioid receptors in the myenteric plexus of the guinea-pig ileum. Eur J Pharmacol 1987; 137: 85–9
- Hutchinson M, Kosterlitz HW, Leslie FM, Waterfield AA, Terenius L. Assessment of the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinocieptive activity but do not substitute for morphine in the dependent monkey. Br J Pharmacol 1975; 55: 541
- Chavkin C, Goldstein A. Specific receptor for the opioid peptide dynorphine: structure-activity relationships. Proc Natl Acad Sci 1981; 78: 6543–7
- Von Voigtlander PF, Lewis RA. Analgesic and mechanistic evaluation of, spiradoline, a potent kappa opioid. J Pharmacol Exp Ther 1988; 246: 259–62
- Kunihara M, Ohyama M, Nakano M, Hayashi S. Analgesic activity of spiradoline mesylate, (U-62066E), a kappa opioid agonist in mice. Life Sci 1989; 45: 1191–8
- Lahti RA, Mickelson MM, McCall JM, Von Voigtlander PF. [3H]U-69593 a highly selective ligand for the opioid receptor. Eur J Pharmacol 1985; 109: 281–4
- Hayashi S, Gleason WA, McFee AS, Park MK. Effects of pH alteration and hypoxia on isolated human intestine. Scand J Gastroenterol 1986; 21: 9–15
- Johnson SM, Costa M, Humphreys CM. Opioid mu and kappa receptors on axons of cholinergic excitatory neurons supplying the circular muscle of guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1988; 388: 397–400
- Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides; multiple agonists and receptors. Nature (London) 1977; 267: 495
- Yoshimura K, Huidobro-Toro JP, Lee N, Loh HH, Way EL. Kappa opioid properties of dynorphin and its peptide fragments on the guinea pig ileum. J Pharmacol Exp Ther 1982; 222: 710
- Cherubini E, North RA. ü and opioids inhibit transmitter release by different mechanisms. Proc Natl Acad Sci 1985; 82: 1860–3
- Leff P, Dougall IG. Estimation of affinities and efficacies for receptor agonists in guinea-pig ileum. Br J Pharmacol 1989; 96: 702–6
- Szerb C. Correlation between acetylcholine release and neuronal activity in the guinea-pig ileum myenteric plexus: effect of morphine. Neuroscience 1982; 7: 327–40
- Paton WDM. The action at morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Br J Pharmacol 1957; 12: 119–27
- Cowie AL, Kostcrlitz HW, Waterfiled AA. Factors influencing the release at acetylcholine from the myenteric plexus in the ileum of the guinea-pig and rabbit. Br J Pharmacol 1978; 64: 565–80
- Paton WDM, Vizi ES, Zar MA. The mechanism of acetylcholine release from parasympathetic nerves. J Physiol (London) 1971; 215: 819–48